BioPontis Alliance for Rare Diseases is dedicated to the advancement of new therapeutic agents for rare diseases. As a global non-profit development hub, BioPontis Alliance for Rare Diseases employs a collaborative approach, forging partnerships with patient organizations and academic researchers to drive innovation. The company’s expertise covers preclinical translational science, early clinical development, patenting, and business relationship management, ensuring promising treatments are ready for uptake by the biopharmaceutical and biotech industry.
BioPontis Alliance for Rare Diseases is located at 13200 Strickland Rd, Raleigh, North Carolina, US. BioPontis Alliance for Rare Diseases is committed to addressing the health needs of individuals affected by rare diseases, often neglected due to their rarity.
BioPontis Alliance for Rare Diseases invites corporate, private, and foundation philanthropic support to expand its reach and impact. The company continues to strengthen its position as a key player in the biotechnology sector. We invite the management team at BioPontis Alliance for Rare Diseases to create a customized and exclusive company showcase and product listing on our platform, further amplifying their visibility and commercial development.
BioPontis Alliance for Rare Diseases se consacre à la promotion de nouveaux agents thérapeutiques pour les maladies rares. En tant que centre mondial de développement à but non lucratif, BioPontis Alliance for Rare Diseases adopte une approche collaborative, forgeant des partenariats avec des organisations de patients et des chercheurs universitaires pour stimuler l'innovation. L'expertise de l'entreprise couvre la science translationnelle préclinique, le développement clinique précoce, le dépôt de brevets et la gestion des relations commerciales, garantissant que les traitements prometteurs soient prêts à être adoptés par l'industrie biopharmaceutique et biotechnologique.
BioPontis Alliance for Rare Diseases est située au 13200 Strickland Rd, Raleigh, Caroline du Nord, États-Unis. BioPontis Alliance for Rare Diseases s'engage à répondre aux besoins de santé des personnes atteintes de maladies rares, souvent négligées en raison de leur rareté.
BioPontis Alliance for Rare Diseases invite les entreprises, les particuliers et les fondations à apporter un soutien philanthropique afin d'étendre sa portée et son impact. L'entreprise continue de renforcer sa position en tant qu'acteur clé du secteur de la biotechnologie. Nous invitons l'équipe de direction de BioPontis Alliance for Rare Diseases à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, augmentant ainsi sa visibilité et son développement commercial.
Compare BioPontis Alliance for Rare Diseases with 3 companies in Biotechnology
| Comparison Field |
BioPontis Alliance for Ra...Main Company |
Candid TherapeuticsView Profile |
Morgan Prestwich - L...View Profile |
Strike Pharma ABView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2024 | 2010 | 2020 |
|
Company Size
|
— | 11-50 | 11-50 | 2-10 |
|
City
|
Raleigh, North Carolina | San Diego, CA | Reigate, Surrey | |
|
Country
|
United States | United States | United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
7 Total Skills
Biotechnology
Rare Diseases
Drug Development
Therapeutic Agents
Non-Profit
Preclinical Development
Clinical Development
|
1 Total
1 Unique
Unique Skills:
Therapeutics
|
54 Total
54 Unique
Unique Skills:
Biotech
Biotech Recruitment
Biotechnology Recruitment
Boards
Business Development
Cell Therapy
+48
|
4 Total
4 Unique
Unique Skills:
CAR-T
Immuno-oncology
Immunotherapy
Personalized medicine
|
Other organizations in the same industry
This company is also known as